Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-05-20 @ 7:00 AM
Study NCT ID:
NCT00778167
Status:
COMPLETED
Last Update Posted:
2014-05-21
First Post:
2008-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: